Belinda Jervis

Belinda Hightower re-joined CYN’s board in 2019 and previously served as the Board Secretary. Belinda was elected as the Board President in 2023.

She is an independent Clinical/Quality Consultant. Belinda has held leadership roles across different functions and made significant contributions towards the development and marketing of drugs, nutritionals and devices. She has held various positions with companies such Abbott Laboratories (AbbVie), Upjohn and GH Besselaar before retiring in 2013. Presently Belinda serves as a Standardards and Compliance Consultant offering support to biotech companies such Akebia Therapeutics, Intellia Therapeutics and Biorasi, LLC. She has worked in alignment with numerous therapeutic areas, international markets and successfully served in the capacity of Inspection Administration for countless regulatory inspections conducted by national and international competent authorities. Belinda is a Registered Nurse and holds a dual Doctorate and Masters in International Business m the Keller Graduate School of Management and a Bachelor’s of Science degree from DePaul University. In her spare time Belinda loves to do calligraphy, listen to music and spend time with her husband and family.

“Hearing about the impact, observing the dedicated staff and seeing the metrics about the work performed and success realized by the community has left me in awe of CYN and its mission to serve families and individuals in need.   It is an honor and pleasure to serve as a member of the Board of Directors for CYN.”